Lantern Pharma Inc.(LTRN)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | Schalop Lee Troy Director | Purchase | 0 | +0.00%97,088 | $1.03 | $100,001 | View SEC filing | |
| 2026-05-14 | KEYSER D JEFFREY Director | Purchase | 0 | +0.00%142,847 | $1.03 | $100,001 | View SEC filing | |
| 2025-06-13 | BIOS Fund I, LP 10% Owner | Sale | -40,000 | -3.67%1,049,859 | $3.09 | $123,600 | View SEC filing | |
| 2025-06-13 | Cavu Management, LP 10% Owner | Sale | -40,000 | -3.67%1,049,859 | $3.09 | $123,600 | View SEC filing | |
| 2025-06-13 | BIOS Fund I, LP 10% Owner | Sale | -61,613 | -5.35%1,089,859 | $3.38 | $208,271 | View SEC filing | |
| 2025-06-13 | Cavu Management, LP 10% Owner | Sale | -61,613 | -5.35%1,089,859 | $3.38 | $208,271 | View SEC filing | |
| 2025-05-29 | BIOS Fund I, LP 10% Owner | Sale | -56,237 | -4.66%1,151,472 | $2.99 | $168,419 | View SEC filing | |
| 2025-05-29 | Cavu Management, LP 10% Owner | Sale | -56,237 | -4.66%1,151,472 | $2.99 | $168,419 | View SEC filing | |
| 2024-05-28 | Cavu Management, LP 10% Owner | Sale | -30,000 | -4.63%618,206 | $6.30 | $189,100 | View SEC filing | |
| 2024-05-28 | BIOS Fund I, LP 10% Owner | Sale | -30,000 | -4.63%618,206 | $6.30 | $189,100 | View SEC filing | |
| 2024-02-29 | BIOS Fund I, LP 10% Owner | Sale | -144,000 | -18.18%648,206 | $4.70 | $676,294 | View SEC filing | |
| 2024-02-29 | Cavu Management, LP 10% Owner | Sale | -144,000 | -18.18%648,206 | $4.70 | $676,294 | View SEC filing | |
| 2024-01-19 | BIOS Fund I, LP 10% Owner | Sale | -58,889 | -6.92%792,206 | $4.20 | $247,334 | View SEC filing | |
| 2024-01-19 | Cavu Management, LP 10% Owner | Sale | -58,889 | -6.92%792,206 | $4.20 | $247,334 | View SEC filing | |
| 2023-12-01 | BIOS Fund I, LP 10% Owner | Sale | -145,348 | -19.78%589,503 | $3.44 | $499,997 | View SEC filing | |
| 2023-12-01 | Cavu Management, LP 10% Owner | Sale | -145,348 | -19.78%589,503 | $3.44 | $499,997 | View SEC filing | |
| 2022-11-09 | Cavu Management, LP 10% Owner | Sale | -350,000 | -18.85%1,506,925 | $4.40 | $1,540,000 | View SEC filing | |
| 2022-11-09 | BIOS Fund I, LP 10% Owner | Sale | -350,000 | -18.85%1,506,925 | $4.40 | $1,540,000 | View SEC filing | |
| 2022-09-07 | BIOS Fund I, LP 10% Owner | Sale | -6,445 | -0.03%26,093 | $5.20 | $33,514 | View SEC filing | |
| 2022-09-07 | Cavu Management, LP 10% Owner | Sale | -6,445 | -0.03%26,093 | $5.20 | $33,514 | View SEC filing | |
| 2020-06-15 | KEYSER D JEFFREY Director | Purchase | +10,000 | +100.00%10,000 | $15.00 | $150,000 | View SEC filing |
1-21 of 21